Antibody persistence 10 years after 1st and 2nd doses of 23-valent pneumococcal polysaccharide vaccine (PN23), and immunogenicity and safety of 2nd and 3rd doses in older adults

Authors
Category Primary study
JournalInternational Journal of Infectious Diseases
Year 2010
This article has no abstract
Epistemonikos ID: 9765d0cf2064041dc5a0e741a0c8bae6367af240
First added on: Feb 28, 2025